FDA Extends NDI Comment Period
The deadline is now December 2.
FDA is extending the comment period for New Dietary Ingredient (NDI) draft guidance to December 2, according to a brief published in the Federal Register last week.
October 3 was the original deadline for submitting comments on the recently published guidance, but murky draft language and concern over economic consequences of NDI applications have left industry wanting more time to mull over the language.
Steve Mister, president and CEO of the Council for Responsible Nutrition (Washington, DC), welcomed the extension because it will allow industry to provide "a more thoughtful and comprehensive response."
To submit your own comments electronically, visit www.regulations.gov.
To submit written comments, write to FDA at the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
